Pentagon · Pete Hegseth · Goldman Sachs · Ars Technica
Pentagon rescinds new testosterone screening policy without explanation
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
Following Defense Secretary Pete Hegseth’s startling announcement in July that the US military would begin mandatory testosterone screening for personnel, the Pentagon released a clinical guidance document on September 2 outlining the new medically questionable policy.
Key facts
- Sent to Ars Technica, the Pentagon said that the document, titled “Clinical Guidance for Health and Human Performance Optimization,” had been temporarily rescinded on September 3 to allow for updates
- Following Defense Secretary Pete Hegseth’s startling announcement in July that the US military would begin mandatory testosterone screening for personnel, the Pentagon released a clinical guidance
- In it, they talked with Bradley Anawalt, the chief of medicine at the University of Washington Medical Center, who specializes in endocrinology and men’s health
- The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell
Summary
The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell. Sent to Ars Technica, the Pentagon said that the document, titled “Clinical Guidance for Health and Human Performance Optimization,” had been temporarily rescinded on September 3 to allow for updates. “The Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members, and enabling peak operational performance,” the Pentagon said. The Pentagon declined to provide more information regarding what was being updated about the guidance and why it needed to be updated so quickly after its release.